{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:12:49Z","timestamp":1768511569116,"version":"3.49.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study evaluates the impact of early oral anticoagulant (OAC) initiation at hospital discharge on functional and safety outcomes in atrial fibrillation (AF)-related acute ischemic stroke (AIS) patients undergoing endovascular therapy (EVT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>AF patients undergoing EVT of symptom onset in AIS were included in this study. Patients were grouped by postoperative anticoagulation status. The patients were regularly followed up 90 days and 1 year after discharge. The primary outcome measure for assessing prognosis is the modified Rankin Scale (mRS) score. The secondary evaluation indicators were the occurrence of recurrent ischemic stroke\/systemic embolism (IS\/SE) outcomes, safety outcomes, and all-cause mortality outcomes within 1 year. The differences in prognostic indicators between the two groups were compared by combining PSM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 296 eligible patients, 113 (38.18%) received anticoagulation at discharge, while 183 (61.82%) did not. Before PSM, the anticoagulation cohort exhibited markedly elevated rates of favorable functional outcomes at 90 days post-discharge (mRS 0\u20132: 60.18% vs. 25.14%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and at 1 year (mRS 0\u20132: 64.60% vs. 30.05%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001), along with a lower all-cause mortality rate within 1 year (16.81% vs. 44.26%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). After PSM, the results demonstrated that the anticoagulation group had elevated rates of favorable functional outcomes at 90 days (55.81% vs. 27.91%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and at 1 year (60.47% vs. 30.23%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). The anticoagulation group had a lower all-cause mortality rate at both 90-day (11.63% vs. 40.70%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and 1-year follow-up (17.44% vs. 50%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). Statistical analysis revealed no significant intergroup differences in terms of IS\/SE recurrence rates, safety outcomes. Multivariate logistic regression modeling identified OAC therapy upon discharge as an independent predictor of improved 90-days (OR\u2009=\u20094.478, 95% CI: 1.122\u201317.874,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.034) and 1 year (OR\u2009=\u20094.168, 95% CI: 1.118\u20135.542,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.033) functional recovery among patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with AF complicated by stroke who underwent EVT and were at no high risk for severe bleeding, OAC therapy is associated with improved functional and mortality outcomes compared with those not receiving OAC. The benefit remained statistically significant following PSM to adjust for intergroup disparities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1622665","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:27:12Z","timestamp":1768458432000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of anticoagulation management following endovascular therapy on prognosis of patients with atrial fibrillation and acute ischemic stroke"],"prefix":"10.3389","volume":"12","author":[{"given":"Yu","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]},{"name":"China Medical University","place":["Shenyang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadiyan","family":"Aierken","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]},{"name":"China Medical University","place":["Shenyang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajie","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]},{"name":"Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]},{"name":"Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]},{"name":"Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tcm.2021.12.001","article-title":"Atrial fibrillation and stroke: a review and new insights","volume":"33","author":"Escudero-Mart\u00ednez","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e077209","DOI":"10.1136\/bmj-2023-077209","article-title":"Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study","volume":"385","author":"Vinter","year":"2024","journal-title":"Br Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"102181","DOI":"10.1016\/j.cpcardiol.2023.102181","article-title":"Atrial fibrillation and stroke: state-of-the-art and future directions","volume":"49","author":"Elsheikh","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1177\/17474930231175807","article-title":"Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: analysis of the ANAFIE registry","volume":"18","author":"Shiozawa","year":"2023","journal-title":"Int J Stroke"},{"key":"B7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/STROKEAHA.123.044487","article-title":"Secular trends in outcomes and impact of novel oral anticoagulants in atrial fibrillation-related acute ischemic stroke","volume":"55","author":"Lee","year":"2024","journal-title":"Stroke"},{"key":"B8","doi-asserted-by":"publisher","first-page":"131369","DOI":"10.1016\/j.ijcard.2023.131369","article-title":"Ischemic stroke and major bleeding while on direct oral anticoagulants in na\u00efve patients with atrial fibrillation: impact of resumption or discontinuation of anticoagulant treatment. A population-based study","volume":"394","author":"Gennaro","year":"2024","journal-title":"Int J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/STROKEAHA.121.036695","article-title":"Practical \u201c1-2-3-4-day\u201d rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation: combined hospital-based cohort study","volume":"53","author":"Kimura","year":"2022","journal-title":"Stroke"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study","volume":"146","author":"Oldgren","year":"2022","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"929304","DOI":"10.3389\/fcvm.2022.929304","article-title":"Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke","volume":"9","author":"Hsu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/joim.13425","article-title":"Endovascular thrombectomy for acute ischemic stroke","volume":"291","author":"Wass\u00e9lius","year":"2022","journal-title":"J Intern Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"594672","DOI":"10.3389\/fneur.2020.594672","article-title":"Pathophysiology of blood-brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery","volume":"11","author":"Bernardo-Castro","year":"2020","journal-title":"Front Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jphys.2013.12.012","article-title":"National institutes of health stroke scale (NIHSS)","volume":"60","author":"Kwah","year":"2014","journal-title":"J Physiother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jphys.2022.05.017","article-title":"Clinimetrics: modified Rankin scale (mRS)","volume":"68","author":"Haggag","year":"2022","journal-title":"J Physiother"},{"key":"B18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/clc.23759","article-title":"Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new-onset acute ischemic stroke: a report from the China atrial fibrillation registry study","volume":"45","author":"Wang","year":"2022","journal-title":"Clin Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s13311-023-01377-1","article-title":"Hemorrhagic conversion of acute ischemic stroke","volume":"20","author":"Zubair","year":"2023","journal-title":"Neurotherapeutics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000527193","article-title":"Predictors of symptomatic intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke: a systematic review and meta-analysis","volume":"52","author":"Dong","year":"2023","journal-title":"Cerebrovasc Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/STROKEAHA.121.035425","article-title":"Clinical and imaging indicators of hemorrhagic transformation in acute ischemic stroke after endovascular thrombectomy","volume":"53","author":"Tian","year":"2022","journal-title":"Stroke"},{"key":"B22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/ijs.12473","article-title":"Antithrombotic treatment at onset of stroke with atrial fibrillation, functional outcome, and fatality: a systematic review and meta-analysis","volume":"10","author":"Hannon","year":"2015","journal-title":"Int J Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medicina58101323","article-title":"Impact of anticoagulants in reducing mortality and disability in cardioembolic stroke patients","volume":"58","author":"Jurj\u0101ns","year":"2022","journal-title":"Medicina"},{"key":"B24","doi-asserted-by":"publisher","first-page":"10760296231213070","DOI":"10.1177\/10760296231213070","article-title":"Efficacy and safety of anticoagulant therapy versus antiplatelet therapy in acute ischemic stroke patients with atrial fibrillation","volume":"29","author":"Yan","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"key":"B25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s42466-022-00207-7","article-title":"Antithrombotic treatment and outcome after endovascular treatment and acute carotid artery stenting in stroke patients with atrial fibrillation","volume":"4","author":"Weller","year":"2022","journal-title":"Neurol Res Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","article-title":"Neuroinflammation: friend and foe for ischemic stroke","volume":"16","author":"Jayaraj","year":"2019","journal-title":"J Neuroinflammation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/CIRCULATIONAHA.124.069324","article-title":"Early versus late initiation of direct oral anticoagulants after ischemic stroke in people with atrial fibrillation and hemorrhagic transformation: prespecified subanalysis of the randomized controlled ELAN trial","volume":"150","author":"Rohner","year":"2024","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e037234","DOI":"10.1136\/bmjopen-2020-037234","article-title":"Dabigatran initiation in patients with non-valvular AF and first acute ischaemic stroke: a retrospective observational study from the SITS registry","volume":"10","author":"Escudero-Martinez","year":"2020","journal-title":"BMJ Open"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1270452","DOI":"10.3389\/fcvm.2023.1270452","article-title":"Research on atrial fibrillation mechanisms and prediction of therapeutic prospects: focus on the autonomic nervous system upstream pathways","volume":"10","author":"Huang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"23969873241300888","DOI":"10.1177\/23969873241300888","article-title":"Time-varying differences in stroke recurrence risk between types of atrial fibrillation based on screening methods and timing of detection","volume":"10","author":"Alvarado-Bolanos","year":"2024","journal-title":"Eur Stroke J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ana.26815","article-title":"Association of the timing of atrial fibrillation detection and insular involvement with the risk of embolic events after acute ischemic stroke","volume":"95","author":"Tokunaga","year":"2024","journal-title":"Ann Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(23)00326-5","article-title":"Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack","volume":"23","author":"Sposato","year":"2024","journal-title":"Lancet Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000520101","article-title":"Differences between atrial fibrillation detected before and after stroke and TIA: a systematic review and meta-analysis","volume":"51","author":"Fridman","year":"2022","journal-title":"Cerebrovasc Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e034861","DOI":"10.1161\/JAHA.124.034861","article-title":"Association between the timing of atrial fibrillation detection and functional outcome following mechanical thrombectomy","volume":"13","author":"Ryu","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.1007\/s00415-024-12671-z","article-title":"Characteristics and outcomes of atrial fibrillation detected before and after acute ischemic stroke","volume":"271","author":"D\u2019Anna","year":"2024","journal-title":"J Neurol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1622665\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:27:14Z","timestamp":1768458434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1622665\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2025.1622665"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1622665","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"1622665"}}